Vyvgart Hytrulo Drug Interactions
Currently displaying a list of 382 drugs known to interact with Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase).
- 45 major drug interactions
- 246 moderate drug interactions
- 91 minor drug interactions
Medications known to interact with Vyvgart Hytrulo
Note: Showing generic names only.
A
- abatacept
- abciximab
- abrocitinib
- acrivastine
- adalimumab
- adenovirus vaccine
- ado-trastuzumab emtansine
- aducanumab
- alefacept
- alemtuzumab
- alirocumab
- allogeneic processed thymus tissue
- aminosalicylic acid
- amivantamab
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- anti-thymocyte globulin (rabbit)
- antihemophilic factor
- asfotase alfa
- ashwaganda
- aspirin
- astemizole
- atezolizumab
- avelumab
- axatilimab
- azatadine
- azathioprine
B
- balsalazide
- bamlanivimab
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- bebtelovimab
- belantamab mafodotin
- belatacept
- belimumab
- benralizumab
- betamethasone
- bevacizumab
- bevacizumab ophthalmic
- bezlotoxumab
- bifidobacterium infantis
- bifidobacterium longum
- bimekizumab
- bismuth subsalicylate
- blinatumomab
- botulism immune globulin
- brentuximab
- brewer's yeast
- brodalumab
- brompheniramine
- budesonide
- bupivacaine
- bupivacaine liposome
- burosumab
C
- canakinumab
- candida albicans extract
- caplacizumab
- carbinoxamine
- cat's claw
- cemiplimab
- certolizumab
- cetirizine
- cetuximab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- chlorcyclizine
- chloroprocaine
- chlorotrianisene
- chlorpheniramine
- cholera vaccine
- cholera vaccine, live
- choline salicylate
- cladribine
- clemastine
- coagulation factor ix
- coccidioidin skin test
- concizumab
- conjugated estrogens
- conjugated estrogens topical
- corticorelin
- corticotropin
- cortisone
- cosibelimab
- cosyntropin
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crizanlizumab
- cyclizine
- cyproheptadine
- cytomegalovirus immune globulin
D
- daclizumab
- daratumumab
- datopotamab deruxtecan
- dengue vaccine
- denosumab
- desloratadine
- deucravacitinib
- dexamethasone
- dexbrompheniramine
- dexchlorpheniramine
- dienestrol topical
- diethylstilbestrol
- diflunisal
- dimethyl fumarate
- dinutuximab
- diphenhydramine
- diroximel fumarate
- donanemab
- dopamine
- dostarlimab
- doxylamine
- dulaglutide
- dupilumab
- durvalumab
E
- echinacea
- eculizumab
- efalizumab
- efbemalenograstim alfa
- elderberry
- elotuzumab
- elranatamab
- emapalumab
- emicizumab
- enfortumab vedotin
- ephedrine
- epinephrine
- eptinezumab
- erenumab
- esterified estrogens
- estradiol
- estradiol topical
- estramustine
- estrone
- estropipate
- estropipate topical
- etanercept
- ethinyl estradiol
- etidocaine
- etrasimod
- evinacumab
- evolocumab
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b immune globulin
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydrocortisone
- hydroxyzine
I
- ibalizumab
- ibritumomab
- idarucizumab
- immune globulin intramuscular
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- immune globulin subcutaneous
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- inotuzumab ozogamicin
- iodine i 131 tositumomab
- ipilimumab
- isatuximab
- ixekizumab
J
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lanadelumab
- lebrikizumab
- lecanemab
- leflunomide
- levobupivacaine
- levocetirizine
- lidocaine
- loncastuximab tesirine
- loratadine
- luspatercept
- lyme disease vaccine
- lymphocyte immune globulin, anti-thy (equine)
M
- magnesium salicylate
- margetuximab
- marstacimab
- measles virus vaccine
- meclizine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mepivacaine
- mepolizumab
- mesalamine
- metaraminol
- methdilazine
- methylprednisolone
- mirikizumab
- mixed respiratory vaccine
- mogamulizumab
- monomethyl fumarate
- mumps skin test antigen
- mumps virus vaccine
- muromonab-cd3
N
- nadofaragene firadenovec
- natalizumab
- naxitamab
- necitumumab
- nemolizumab
- niraparib
- nirsevimab
- nivolumab
- norepinephrine
O
P
- palivizumab
- panitumumab
- pembrolizumab
- pemivibart
- pertussis, acellular
- pertuzumab
- phenindamine
- phenylephrine
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- pozelimab
- prednisolone
- prednisone
- prilocaine
- procaine
- promethazine
- propiomazine
- pyrilamine
Q
R
- rabies immune globulin, human
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ramucirumab
- ravulizumab
- reslizumab
- respiratory syncytial virus immune globulin
- retifanlimab
- rho (d) immune globulin
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- romiplostim
- romosozumab
- ropivacaine
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
S
- saccharomyces boulardii lyo
- sacituzumab govitecan
- salsalate
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- siltuximab
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- sodium salicylate
- sodium thiosalicylate
- sotatercept
- sotrovimab
- spesolimab
- staphage lysate (spl)
- streptococcus salivarius
- sulfasalazine
T
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tarlatamab
- teclistamab
- teprotumumab
- terfenadine
- teriflunomide
- tetanus immune globulin
- tetanus toxoid
- tetracaine
- tezepelumab
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tislelizumab
- tisotumab vedotin
- tocilizumab
- tofacitinib
- toripalimab
- tositumomab
- tralokinumab
- trastuzumab
- tremelimumab
- triamcinolone
- trichophyton skin test
- trimeprazine
- tripelennamine
- triprolidine
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
- vaccinia immune globulin
- vamorolone
- varicella virus vaccine
- varicella zoster immune globulin
- vedolizumab
- vilobelimab
- vitamin e
- voclosporin
Y
Z
- zanidatamab
- zenocutuzumab
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- ziv-aflibercept
- zolbetuximab
- zoster vaccine live
- zoster vaccine, recombinant
Vyvgart Hytrulo disease interactions
There are 2 disease interactions with Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase) which include:
More about Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase)
- Vyvgart Hytrulo consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.